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Abstract
Interleukin-4 (IL-4) is an anti-inflammatory and analgesic cytokine that induces opioid receptor transcription. We
investigated IL-4 knockout (ko) mice to characterize their pain behavior before and after chronic constriction injury (CCI) of
the sciatic nerve as a model for neuropathic pain. We investigated opioid responsivity and measured cytokine and opioid
receptor gene expression in the peripheral and central nervous system (PNS, CNS) of IL-4 ko mice in comparison with
wildtype (wt) mice. Naı ¨ve IL-4 ko mice displayed tactile allodynia (wt: 0.45 g; ko: 0.18 g; p,0.001), while responses to heat
and cold stimuli and to muscle pressure were not different. No compensatory changes in the gene expression of tumor
necrosis factor-alpha (TNF), IL-1b, IL-10, and IL-13 were found in the PNS and CNS of naı ¨ve IL-4 ko mice. However, IL-1b gene
expression was stronger in the sciatic nerve of IL-4 ko mice (p,0.001) 28 days after CCI and only IL-4 ko mice had elevated
IL-10 gene expression (p=0.014). Remarkably, CCI induced TNF (p,0.01), IL-1b (p,0.05), IL-10 (p,0.05), and IL-13
(p,0.001) gene expression exclusively in the ipsilateral spinal cord of IL-4 ko mice. The compensatory overexpression of the
anti-inflammatory and analgesic cytokines IL-10 and IL-13 in the spinal cord of IL-4 ko mice may explain the lack of
genotype differences for pain behavior after CCI. Additionally, CCI induced gene expression of m, k, and d opioid receptors
in the contralateral cortex and thalamus of IL-4 ko mice, paralleled by fast onset of morphine analgesia, but not in wt mice.
We conclude that a lack of IL-4 leads to mechanical sensitivity; the compensatory hyperexpression of analgesic cytokines
and opioid receptors after CCI, in turn, protects IL-4 ko mice from enhanced pain behavior after nerve lesion.
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Introduction
The immune system plays a major role in the induction and
maintenance of neuropathic pain [1,2]. Balanced interactions
between immune cells, immune cell modulatory molecules, cytokines,
and chemokines are necessary for pain homeostasis. The major
implication of this balance becomes apparent when parts of the
network are missing or dysfunctional. For instance, lack of the T-cell
co-inhibitory molecule B7-H1 leads to increased T-cell proliferation
and pro-inflammatory cytokine production with prolonged pain
behavior after peripheral nerve lesion [3]. In many animal models,
pro-inflammatory cytokines are algesic and anti-inflammatory
cytokines are analgesic, see [4] for review. The anti-inflammatory
cytokines interleukin (IL)-4, IL-10, and IL-13 have analgesic effects in
inflammatory and neuropathic pain models [5–10]. IL-4 and IL-13
share the same receptor and act via the signal transducer and activator
of transcription 6 (STAT6) pathway. IL-4 is of particular interest,
since it links the immune system to the opioid system by inducing m
and d opioid receptor (MOR, DOR) transcription [11,12].
In humans an imbalance of the expression of pro- and anti-
inflammatory cytokines is assumed to be one factor in inducing
and maintaining pain. We recently showed altered local and
systemic cytokine profiles in patients with several different chronic
pain disorders [13–16]. Reduced systemic expression of IL-4 and
IL-10 was found in most of these patients. We therefore
hypothesized that this reduction of anti-inflammatory cytokines
might be causally related to pain and that IL-4 knockout (ko) mice
would display altered pain behavior. Since IL-4 induces MOR and
DOR transcription in neuronal cell cultures [11,12], we further
hypothesized that IL-4 ko mice might respond differently to
morphine treatment. We used chronic constriction injury (CCI) of
the right sciatic nerve as a model of neuropathic pain and set out
to characterize IL-4 ko mice as to their pain behavior, opioid
response and cytokine and opioid receptor gene expression before
and after CCI. We show that IL-4 deficiency leads to mechanical
allodynia and changes spinal cytokine regulation after CCI.
Methods
Ethic statement
All experiments were approved by the Bavarian State
authorities (Regierung von Unterfranken, # 02/08). Mice were
held at the animal facilities of the Department of Neurology,
University of Wu ¨rzburg under standard conditions with food and
water access ad libitum. Animal use and care were in accordance
with the institutional guidelines.
Animals and surgery
We investigated 30 IL-4 ko mice and 30 wild type (wt) mice of
C57Bl/6J background. The mean age was eight to ten weeks. IL-4
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Jackson Laboratories (Maine, USA), wt C57Bl/6J animals were
purchased from Charles River Laboratories (Sulzfeld, Germany).
Ten mice of each group received CCI at the right sciatic nerve,
while ten mice served as unoperated controls. Further 10 mice per
genotype were used for the pharmacological experiments (see
below). The procedure of CCI of the sciatic nerve followed the
original description [17] with modifications for mice [18]. In brief,
the right sciatic nerve was exposed under intraperitoneal (i.p.)
isoflurane narcosis and three ligatures (7-0 prolene) were placed
around the sciatic nerve proximal to the trifurcation with a
distance of one mm between each ligature. The ligatures were
loosely tied until a short flick of the ipsilateral hind limb was
observed.
Behavioral tests
All behavioral tests were performed by an experienced
investigator blinded as to genotype and intervention. Paw
withdrawal latencies to heat were measured according to the method
of Hargreaves [19] applying a standard Ugo Basile Algesiometer
(Comerio, Italy). The animals were placed on a glass surface and a
radiant heat source was positioned under one hind paw. The time
to paw withdrawal was recorded automatically. To avoid tissue
damage the time limit for heat application was set to 15 seconds.
Each hind paw was tested three times.
The von-Frey test based on the up-and-down-method was used
to test for the paw withdrawal thresholds to tactile stimulation [20].
Animals were placed in plexiglass cages on a wire mesh. The
plantar surface of the hind paws was touched with a von-Frey
monofilament starting at a hair value of 0.69 g. When the animal
withdrew its hind paw upon administration of mild pressure the
next finer von-Frey filament was used. If the animal did not react
to this stimulation, the next stronger von-Frey filament was
applied. Each hind paw was tested three times. The 50%
withdrawal threshold (i.e. force of the von-Frey hair to which an
animal reacts in 50% of the administrations) was recorded.
The acetone test was used to investigate paw withdrawal latencies
to cold. Mice were placed in plexiglass cages on a wire mesh. The
plantar surface of the hind paw was touched with a drop of water
at body temperature as a control condition and the reaction of the
mouse was recoded (paw withdrawal or no paw withdrawal).
Afterwards the paw was dried and a drop of acetone was applied.
The total time of paw withdrawal (i.e. time until the withdrawn
hind paw was placed back on the wire mesh for at least two
seconds) was recorded. The cut off time was 30 seconds.
Using the Randall-Selitto test (Ugo Basile algesimeter, Chicago,
USA) the withdrawal latency to muscle pressure was investigated. The
test was applied to test for muscle tenderness, which is a leading
clinical feature in patients with chronic pain and reduced IL-4
levels [13]. The animal was held with the head in a cotton sock for
calming and the gastrocnemius muscle was placed in the Randall-
Selitto device. Pressure to the muscle was slowly increased until the
animal withdrew its hindlimb. The time until hindlimb withdrawal
was recorded.
Thewithdrawallatenciestoheatandthewithdrawalthresholds tovon-Frey
hairs were performed at baseline and up to day 28 after CCI at
regular time points (twice prior to CCI; days 3, 7, 9, 14, and 28 after
CCI). The acetone test and the test for withdrawal latencies to muscle
pressure were performed in naı ¨ve mice of both genotypes at baseline
only to keep the experimental stress on the animals limited.
Pharmacological treatment
At day seven after CCI five mice of each group received
morphine i.p. (Merck, Germany) at a dosage of 10 mg/kg body
weight. The choice of this dose based on pilot studies showing the
best analgesic effect with least behavioral disturbance. Another five
mice in each group received normal saline as a control. Behavioral
tests were performed at 2, 4, and 6 hours after morphine
administration.
Tissue collection
Twenty-eight days after CCI mice were exsanguinated and
euthanized in deep isoflurane anesthesia and tissue was collected
for qRT-PCR studies. At this time point pain behavior was still
present in CCI mice of both genotypes. The ipsi- and
contralateral sciatic nerves and the ipsi- and contralateral lumbar
dorsal root ganglia (DRG) L4 and L5 were dissected. The
collected ipsilateral nerve contained the segment from under the
ligatures to 1 cm proximal to the first ligature. An equivalent
segment of the contralateral sciatic nerve was collected.
Additionally, the frontal cortex, hippocampus, hypothalamus,
thalamus, pons, and the lumbar and cervical spinal cord were
dissected. Except for the control animals, tissue from the ipsi- and
contralateral side was collected separately. For the correct
localisation of the dissected brain areas we used the online
mouse brain library (www.mbl.org). Tissue was dissected for
qRT-PCR using a dissection microscope (Zeiss, Oberkochen,
Germany) and was immediately flash-frozen in liquid nitrogen
and stored at 280uC before further processing.
Gene expression analysis
mRNA extraction: mRNA extraction from mouse nervous tissue
was performed following the method of Chomczynski [21] with
little modification as described elsewhere [22].
Reverse transcription PCR: All PCR reagents and cyclers were
obtained from Applied Biosystems, Darmstadt, Germany. For
reverse transcription PCR we used TaqMan Reverse Transcrip-
tion ReagentsH. The 100 ml reaction contained 500 ng of mRNA
and the following reagents (per sample): 106 Reaction Buffer
(10 ml), 10 mM dNTPs (20 ml), 25 mM MgCl2 (22 ml), Random
Hexameres (5 ml), RNAse Inhibitor (2 ml) and 50 U/ml Multi-
scribe Reverse Transcriptase (6.25 ml). The 96-well GeneAmpH
PCR System 9700 cycler was employed for the reaction. The
cycler conditions were: 10 min, 38uC; 60 min, 48uC; 25 min,
95uC.
qRT-PCR: The Assay-IDs of the investigated target genes are
given in brackets. We investigated the relative gene expression
of the pro-inflammatory cytokines tumor necrosis factor-alpha
(TNF; Mm00443258_m1), IL-1b (Mm00434228_m1), the anti-
inflammatory cytokines IL-10 (Mm00439616_m1), and IL-13
(Mm00434204_m1) in the peripheral nervous system and the
spinal cord. IL-13 was chosen because it shares the IL-4
receptor and several IL-4 functions and may be compensatorily
regulated.
Gene expression of the opioid receptors m (Mm00440568_m1),
d (Mm00443063_m1), and k (Mm00440561_m1) were investigat-
ed in the brain (frontal cortex, hippocampus, hypothalamus,
thalamus, and pons) and in the ipsi- and contralateral spinal cord.
Five ml of cDNA were taken for qRT-PCR, which was performed
in the GeneAmp 7700 sequence detection systemH capable of
fluorescence measuring using TaqMan Universal Master MixH as
previously described [22].
Statistical analysis
For statistical analysis and graph design SPSS software Version
17 was employed (Munich, Germany). The data of behavioral
testing showed normal distribution in the Kolmogorow-Smirnow-
test. Therefore ANOVA with post hoc Tukey correction was
IL-4 and Pain
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illustrated as dot plots giving the mean and the standard error of
the mean (SEM). Since our mRNA data did not show a normal
distribution we used the non-parametric Mann-Whitney-U-test
for pairwise comparison of the distinct time points with
Bonferroni correction. Statistical significance was assumed at
p,0.05. The qRT-PCR data are illustrated as box- and whisker
plots giving the median, the upper 75% and lower 25%
percentiles and the minimum and maximum values.
Results
IL-4 ko mice are hypersensitive to tactile stimuli
While baseline paw withdrawal latencies to heat were not
different between naı ¨ve IL-4 ko and wt mice (Fig. 1A), naı ¨ve IL-4
ko mice had lower paw withdrawal thresholds to von-Frey hairs
indicative of mechanical allodynia (p,0.001; Fig. 1B). Paw
withdrawal latencies upon cold stimulation and hind limb
withdrawal latencies upon muscle pressure were not different
between genotypes (Fig. 1C, D).
After CCI both IL-4 ko and wt mice developed thermal
hypersensitivity (p,0.001 wt and ko; Fig. 2A) and wt mice
developed mechanical hypersensitivity (wt: p=0.009; Fig. 2B),
which started three days after injury and lasted up to 28 days,
without differences between genotypes. IL-4 ko mice did not
display a further decrease in mechanical withdrawal thresholds
(Fig. 2B). Unexpectedly, only IL-4 ko mice showed an analgesic
response in the tests for thermal (p=0.02; Fig. 2C) and
mechanical sensitivity (p=0.046; Fig. 2D) two hours after
morphine administration at day seven post surgery, while
withdrawal latencies and thresholds did not normalize in wt
mice.
CCI induces a stronger pro- and anti-inflammatory
cytokine response in the sciatic nerve of IL-4 ko mice and
increases cytokine gene expression in the ipsilateral
spinal cord exclusively in IL-4 ko mice
Naı ¨ve IL-4 ko and wt mice did not differ in their TNF, IL-1b,
IL-10, and IL-13 gene expression in sciatic nerve, lumbar and
cervical spinal cord, and DRG. IL-13 was undetectable in sciatic
nerve of both genotypes, as previously described [23].
Four weeks after CCI, both IL-4 ko and wt mice displayed
elevated TNF (ko: p,0.001; wt: p=0.007) and IL-1b (p,0.001 ko
and wt; Fig. 3A) gene expression in the ipsilateral sciatic nerve
compared to unoperated control animals. The increase in IL-1b
gene expression was higher in IL-4 ko mice (p,0.001) and only
IL-4 ko mice had elevated IL-10 gene expression (p=0.014;
Fig. 3A). In the lumbar spinal cord only IL-4 ko mice displayed
elevated TNF (p=0.001), IL-1b (p=0.024), IL-10 (p=0.032), and
IL-13 (p=0.001; Fig. 3B) gene expression four weeks after CCI.
This increase was higher compared to wt mice after CCI (TNF:
p=0.002; IL-1ß: p,0.001; IL-10: p=0.011; IL-13: p=0.026).
CCI induces an increase in opioid gene expression in the
contralateral thalamus of IL-4 mice
Baseline gene expression of MOR, DOR, and KOR in the
investigated brain areas frontal cortex, thalamus, hypothalamus,
and pons of naı ¨ve mice did not differ between genotypes. At 28
days after CCI, gene expression of the three opioid receptors did
not change in pons and hypothalamus of both genotypes, which
served as control areas. In the contralateral frontal cortex MOR gene
expression decreased after CCI in IL-4 ko mice and in wt mice (ko:
p=0.003; wt: p=0.004; Fig. 4A). DOR gene expression did not
change in both genotypes (Fig. 4B). KOR gene expression
Figure 1. Behavioral tests in naı ¨ve IL-4 ko and wt mice. The bars illustrate the results of the behavioral tests in naı ¨ve wt and IL-4 ko mice. A) IL-
4 ko mice do not differ from wt mice in withdrawal latencies to heat. B) IL-4 ko mice have reduced paw withdrawal thresholds to mechanical
stimulation with von-Frey filaments (***p,0.001). IL-4 ko mice do not differ from wt mice in paw withdrawal time to acetone (C), and in withdrawal
latencies of the hind limb upon pressure to the gastrocnemius muscle (D).
doi:10.1371/journal.pone.0028205.g001
IL-4 and Pain
PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e28205decreased both in wt mice (n.s.) and in IL-4 ko mice (p,0.001;
Fig. 4C). In the contralateral thalamus MOR did not change in wt
mice and increased tendentially in IL-4 ko mice (n.s.; Fig. 4A).
DOR gene expression increased in both genotypes (p,0.001,
Fig. 4B) and was higher in IL-4 ko mice (n.s.). KOR gene
expression increased only in IL-4 ko mice (p,0.001; Fig. 4C).
After CCI only KOR gene expression in the contralateral
thalamus was higher in IL-4 ko mice compared to wt mice
(p=0.056). In the spinal cord we found no intergroup difference
for the gene expression of MOR, KOR, and DOR and CCI did
not lead to changes in the expression levels of these genes in wt and
IL-4 ko mice (Fig. 5).
Discussion
The anti-inflammatory cytokine IL-4 has analgesic effects in
animal models [5,7] and there is evidence from clinical studies that
low IL-4 levels may be associated with pain [13,14]. We used IL-4
deficient mice to investigate whether an innate lack of IL-4 leads to
increased pain behavior and altered morphine responsiveness
compared to wt mice, since IL-4 is one important inducer of
opioid receptor transcription [11,12]. Our main findings are that
naı ¨ve IL-4 ko mice indeed are hypersensitive to tactile stimuli and
that CCI leads to an increase in spinal pro- and especially anti-
inflammatory cytokine gene expression exclusively in IL-4 ko
mice.
Studies using cytokine ko mice to investigate pain behavior have
given ample evidence for the algesic effect of pro-inflammatory
cytokines: for instance, mice with an innate lack of IL-1 [24] or IL-
6 [25] display reduced pain behavior - either naı ¨ve or after nerve
injury. The investigation of the innate lack of anti-inflammatory
cytokines and systems in pain development and maintenance has
given complementary results: IL-10 deficiency is associated with
enhanced pain behavior [26]; the lack of the co-inhibitory
molecule B7-H1 leads to mechanical hypersensitivity, increased
pro-inflammatory cytokine gene expression and prolonged pain
behavior after CCI [3]. Here we show that naı ¨ve IL-4 ko mice
have tactile hypersensitivity. Having excluded innate differences in
Figure 2. Analgesic effect of morphine in IL-4 ko and wt mice. Paw withdrawal latencies to thermal stimuli and withdrawal thresholds to von
Frey hairs in wt and IL-4 ko mice after CCI (A, B) and additional morphine treatment (C, D). CCI leads to thermal (A) and mechanical (B) hypersensitivity
lasting up to day 28 after CCI. Mice received morphine i.p. (abbreviated as M in the graphs) at day seven post-surgery. Only IL-4 ko mice showed
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cytokines in naı ¨ve IL-4 ko mice, we consider it very likely that the
lack of IL-4 and the tactile hypersensitivity are causally related.
It is not surprising that IL-4 deficiency leads to tactile
hypersensitivity and spares thermal sensitivity. Thermal and tactile
sensations follow separate spinal pathways and can be affected
separately. It is known that depending on modality (e.g.
mechanical vs. thermal) and status (naı ¨ve vs. after intervention)
pain behavior in cytokine ko mice is differentially controlled [27–
30]. For example, lesion of dorsal column neurons can selectively
attenuate tactile allodynia [28]. Why lack of IL-4 leads to
mechanical allodynia in the naı ¨ve animal is not clear yet. It is
well known that pro-inflammatory cytokines like IL-1 or TNF can
influence electrical excitability of nociceptive neurons [31,32]. Few
studies have investigated the potential role of IL-4 in cell
excitability. In an early study IL-4 was shown to activate ion
channels on B-lymphocytes [33]. IL-4 also induces rapid and big
increases in the activity of large-conductance, calcium-activated
potassium channels in smooth muscle cells [34]. IL-4 also affects
the electrical properties of spinal neurons by modifying the
function of ion currents [35]. One possibility to explain
mechanical allodynia in naı ¨ve IL-4 ko mice might therefore be
that IL-4 ko mice have a reduction in their central inhibitory
neurotransmission. In pilot experiments the analysis of spinal
single unit recordings gave first indications towards an increased
Figure 3. Cytokine gene expression before and after CCI. The
box- and whisker plots illustrate the relative gene expression of pro-
and anti-inflammatory cytokines in the ipsilateral sciatic nerve (A), and
ipsilateral lumbar spinal cord (B) 28 days after CCI. A) CCI leads to an
increase in TNF and IL-1ß gene expression in the ipsilateral sciatic nerve.
The increase in IL-1ß gene expression is higher in IL-4 ko mice
compared to wt mice. IL-10 gene expression increases only in IL-4 ko
mice. B) CCI leads to an increase in TNF, IL-1ß, IL-10, and IL-13 gene
expression only in IL-4 ko mice; this increase is higher compared to wt
mice after CCI (TNF: p=0.002; IL-1ß: p,0.001; IL-10: p=0.011; IL-13:
p=0.026). Asterisk: *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0028205.g003
Figure 4. Cerebral opioid receptor gene expression in IL-4 ko
and wt mice before and after CCI. The box- and whisker plots
illustrate the relative gene expression of the opioid receptors MOR (A),
DOR (B), and KOR (C) in the contralateral frontal cortex and thalamus at
day 28 after CCI. A) MOR gene expression decreases in the contralateral
frontal cortex in IL-4 ko mice and in wt mice. B) DOR gene expression
increases in the contralateral thalamus in both wt and IL-4 ko mice. C)
KOR gene expression decreases in the contralateral frontal cortex of IL-4
ko and wt (n.s.) mice and increases in the contralateral thalamus only in
IL-4 ko mice. Asterisk: *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0028205.g004
IL-4 and Pain
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stimulation with an innocuous von-Frey hair (Schießer, U ¨c ¸eyler,
Sommer unpublished data).
Naı ¨ve IL-4 ko mice are hypersensitive to mechanical stimulation
and no further drop of the mechanical withdrawal thresholds is
observed after CCI. This is mostly due to the fact that the
mechanical withdrawal thresholds are already very low at baseline
and a further reduction exceeds the sensitivity of behavioral tests.
The exclusive increase of pro- but especially anti-inflammatory
cytokines in the ipsilateral spinal cord of IL-4 ko mice may also play
a role. IL-4 and IL-10 expression can attenuate mechanical
allodynia [36]. The lack of IL-4 alone with obviously no
compensatory change in cytokine expression, as in the naı ¨ve mice,
leads to the phenotype of tactile hypersensitivity. However, if the
system is challenged e.g. by CCI then especially anti-inflammatory
andanalgesic cytokinesareupregulatedmuch strongercomparedto
wt mice and protect the organism from further pain.
Opioid receptor gene expression did not differ between naı ¨ve
IL-4 ko and wt mice in brain and spinal cord. Interestingly,
morphine responses were observed only in IL-4 ko mice after CCI.
This was paralleled by an increase in contralateral thalamic DOR
and KOR gene expression exclusively in IL-4 ko mice, whereas wt
mice only had an increase in contralateral thalamic DOR.
Although a key inducer of opioid receptors is missing (i.e. IL-4),
this rapid opioid receptor gene regulation probably is due to
triggers of opioid receptor expression that are more active in IL-4
ko mice: 1) Pain itself is a potent central opioid receptor inducer
[25]. Taking into account that naı ¨ve IL-4 ko mice already have
mechanical hypersensitivity it is plausible that a further pain
trigger like CCI leads to a compensatory stronger opioid receptor
gene expression; 2) Other cytokines are also potent inducers of the
opioid receptor and peptide production [26,27,33] and IL-4 ko
mice displayed a much stronger pro- and anti-inflammatory
response. The finding that KOR and MOR gene expression did
not change or even decreased in contralateral cortex and thalamus
of wt mice after peripheral nerve lesion is in keeping with earlier
studies [37]. In a recent functional study MOR-mediated G-
protein activity was also altered by CCI and there was a brain
region specific decrease in MOR sensitivity [38]. In a human study
chronic pain caused by a peripheral nerve lesion led to a decrease
of central MOR availability [39].
Of note, our gene expression analysis was performed on tissue
collected at day 28 after CCI. In an earlier study we had shown
that spinal gene expression of pro- and anti-inflammatory
cytokines drops within the first six hours after CCI, but is back
to normal values already after 10–12 hours and keeps normal up
to seven days in wt mice [40]. In rat lumbar spinal cord TNF, IL-
1, and IL-6 gene expression peaked between day 1 and 6 after
CCI and were back to normal at day 28 [41]. Our results for
absent spinal cytokine regulation in wt mice 28 days after CCI are
therefore in keeping with the literature. The increase in spinal
cytokine expression in IL-4 ko mice is therefore intriguing and
points to a disinhibition in spinal cytokine regulation in this
genotype after nerve injury.
In conclusion our study shows, that 1) naı ¨ve IL-4 ko mice are
mechanically hypersensitive, while CCI does not lead to
behavioral changes other than in wt mice up to 28 days after
surgery; 2) morphine responsiveness occurs even earlier in IL-4 ko
mice; 3) cytokine and opioid gene expression is not different
between naı ¨ve genotypes; however, CCI leads to a disinhibited
increase in peripheral and spinal pro- and anti-inflammatory gene
expression and also to an increase in contralateral thalamic opioid
receptor gene expression in IL-4 ko mice. The cytokine-pain
relation obviously is more complex than a unidimensional
connection between the lack of one cytokine to measurable
behavioral changes. However, the fact that IL-4 deficiency results
in increased pain behavior upon tactile mechanical stimulation is
intriguingly similar to findings in patients with chronic widespread
pain [42] [U ¨c ¸eyler, Sommer unpublished data] and further studies
addressing downstream mechanisms will help to better understand
the role of IL-4 in pain.
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